Search filters

List of works by Takashi Sasaki

Absence of Drug-Drug Interactions Between Luseogliflozin, a Sodium-Glucose Co-transporter-2 Inhibitor, and Various Oral Antidiabetic Drugs in Healthy Japanese Males

scientific article published on 15 May 2015

Corrigendum

scientific article published on 22 September 2015

Differentiation-induced insulin secretion from nonendocrine cells with engineered human proinsulin cDNA.

scientific article

Dose-finding study of luseogliflozin in Japanese patients with type 2 diabetes mellitus: a 12-week, randomized, double-blind, placebo-controlled, phase II study

scientific article published on 15 April 2014

Efficacy and Safety of the SGLT2 Inhibitor Luseogliflozin in Japanese Patients With Type 2 Diabetes Mellitus Stratified According to Baseline Body Mass Index: Pooled Analysis of Data From 52-Week Phase III Trials.

scientific article

Efficacy and safety of luseogliflozin added to insulin therapy in Japanese patients with type 2 diabetes: a multicenter, 52-week, clinical study with a 16-week, double-blind period and a 36-week, open-label period

scientific article published on 15 February 2018

Efficacy and safety of luseogliflozin added to various oral antidiabetic drugs in Japanese patients with type 2 diabetes mellitus

scientific article published on 10 January 2015

Efficacy and safety of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, phase 3 study.

scientific article published on 29 April 2014

Efficacy and safety of luseogliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: a 12-week, randomized, placebo-controlled, phase II study

scientific article published on 19 March 2014

Epigenetics: Reprogrammable interface of the genome and environments

scientific article published on March 2014

Fifty-two-week long-term clinical study of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus inadequately controlled with diet and exercise.

scientific article published on 12 May 2015

Gene and cell-based therapy for diabetes mellitus: endocrine gene therapeutics.

scientific article

Genetic association of glutathione peroxidase-1 with coronary artery calcification in type 2 diabetes: a case control study with multi-slice computed tomography.

scientific article

High-throughput screening of small interfering ribonucleic acid identifies important modulators in islet dysfunction and apoptosis

scientific article published on 30 September 2014

In vitro and pathological investigations of MODY5 with the R276X-HNF1beta (TCF2) mutation.

scientific article

Influence of Renal Function on the 52-Week Efficacy and Safety of the Sodium Glucose Cotransporter 2 Inhibitor Luseogliflozin in Japanese Patients with Type 2 Diabetes Mellitus.

scientific article published on 21 December 2015

Novel hormonal delivery method using the ink-jet technology: application to pulmonary insulin therapies.

scientific article published on 15 March 2011

PPARgamma2 pro12Ala polymorphism and insulin resistance in Japanese hypertensive patients.

scientific article

Pharmacokinetics and Pharmacodynamics of Luseogliflozin, a Selective SGLT2 Inhibitor, in Japanese Patients With Type 2 Diabetes With Mild to Severe Renal Impairment.

scientific article published on 25 April 2018

Pharmacokinetics, Pharmacodynamics, and Safety of Luseogliflozin in Japanese Patients with Type 2 Diabetes Mellitus: A Randomized, Single-blind, Placebo-controlled Trial.

scientific article published on 9 April 2015

Piccolo, a Ca2+ sensor in pancreatic beta-cells. Involvement of cAMP-GEFII.Rim2. Piccolo complex in cAMP-dependent exocytosis

scientific journal article

Preferential transmission of maternal allele with DQA1*0301-DQB1*0302 haplotype to affected offspring in families with type 1 diabetes

scientific article published on 01 January 1999

Safety, pharmacokinetics, and pharmacodynamics of single and multiple luseogliflozin dosing in healthy Japanese males: a randomized, single-blind, placebo-controlled trial.

scientific article published on 18 February 2014

Sarcopenia, frailty circle, and treatment with SGLT2 inhibitors

scientific article published on 30 November 2018

Sodium-glucose cotransporter 2 inhibitor-induced changes in body composition and simultaneous changes in metabolic profile: 52-week prospective LIGHT (Luseogliflozin: the Components of Weight Loss in Japanese Patients with Type 2 Diabetes Mellitus)

scientific article published on 16 May 2018

Sodium-glucose cotransporter-2 inhibitor luseogliflozin added to glucagon-like peptide 1 receptor agonist liraglutide improves glycemic control with bodyweight and fat mass reductions in Japanese patients with type 2 diabetes: A 52-week, open-label,

scientific article

Temporal and Spatial Cellular Distribution of Neural Crest Derivatives and Alpha Cells during Islet Development

scientific article published on 15 February 2012